Xuanzhu Biopharmaceutical Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	May '26 May 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	11,882	36,515	-	-	-	-
Enterprise Value	11,157	36,396	-	-	-	-
Last Close Price	22.94	70.50	-	-	-	-
PS Ratio	206.24	633.81	-	-	-	-
PB Ratio	7.79	23.95	-	-	-	-
P/TBV Ratio	10.34	31.77	-	-	-	-
EV/Sales Ratio	193.65	631.74	-	-	-	-
Debt / Equity Ratio	0	0	0.00	0.02	0.02	0
Net Debt / Equity Ratio	-0.48	-0.48	-0.26	-0.39	-0.68	-0.71
Net Debt / EBITDA Ratio	3.17	3.17	0.46	1.37	3.02	4.29
Net Debt / FCF Ratio	3.10	3.10	1.92	3.68	2.47	3.62
Asset Turnover	0.04	0.04	0.02	-	-	-
Inventory Turnover	0.36	0.36	0.26	-	-	-
Quick Ratio	3.04	3.04	1.45	3.24	19.95	14.26
Current Ratio	3.75	3.75	2.06	3.79	21.28	14.95
Return on Equity (ROE)	-21.10%	-21.10%	-53.84%	-	-29.47%	-16.87%
Return on Assets (ROA)	-10.28%	-10.28%	-27.99%	-	-15.83%	-14.54%
Return on Capital Employed (ROCE)	-16.50%	-16.50%	-55.40%	-28.80%	-23.00%	-17.70%
Earnings Yield	-2.30%	-0.75%	-	-	-	-
FCF Yield	-1.97%	-0.64%	-	-	-	-
Buyback Yield / Dilution	-3.15%	-3.15%	-	-14.22%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.